Markets
markets
Luke Kawa
1/21/25

General Motors pops higher as Deutsche Bank says it’s a buy

“General Motors has consistently executed well in the midst of macro uncertainties, and we think this will continue to position the company well for 2025, amid a lingering EV slowdown, tariff concerns, and potential policy changes,” Deutsche Bank analyst Edison Yu said in upgrading GM stock to “buy” from “hold” and hiking his price target by $4 to $60.

Shares of GM are up more than 2.5% as of 11:10 a.m. ET, a jump that stands in stark contrast to the slump in electric-vehicle stocks.

What’s been encouraging, according to the analyst, is not necessarily what the company is doing right but rather its willingness to admit when things are wrong and pivot rather than throwing good money after bad. Cases in point: the firm taking restructuring and write-down charges on its joint venture in China, and shuttering Cruise, its robotaxi unit. These shifts should begin to provide some relief for the automaker’s bottom line this year, per Yu.

Now General Motors can focus on one of the things American companies do best: making money, and using that money to repurchase their own stock.

“The company will have completed its $6 billion repurchase plan (post the $10 billion accelerated share repurchase) by early 2025 and we expect continued aggressive buybacks beyond that,” Yu wrote.

More Markets

See all Markets
Oracle Wall Street Revisions

Analysts revise up anything and everything they thought about Oracle

After the company’s bombshell earnings this week, Wall Street thinks Oracle’s trajectory has changed.

markets

Six Flags pops after reiterating its guidance as theme park attendance rebounds

Six Flags shares rose more than 7% today after the company reported a rebound in attendance and early season-pass sales heading into the fall. The nine-week period ending August 31 saw 17.8 million guests, up about 2% from the same stretch in 2024, with stronger momentum in the final four weeks. 

More importantly, Six Flags reaffirmed its full-year adjusted EBITDA guidance of $860 million to $910 million, showing confidence that its cost and operations strategy can stay strong for the duration of the year. Riding that wave, Six Flags also said early 2026 season pass unit sales are pacing ahead of last year, and average season pass prices are up around 3%.

The good vibes come despite a drop in in-park per capita spending, especially from admissions, where promotions and changes to attendance mix (which parks or days guests visit) have weighed. Earlier this week, the amusement giant extended a new agreement that extended its position as the exclusive amusement park partner for Peanuts™ in North America through 2030.

Despite the rally, Six Flags shares are down around 52% year-to-date.

markets

Rivian turns red on the year, squeezed by a recall and the looming end of the EV tax credit

Shares of EV maker Rivian are down more than 5% on Friday following the company’s recall of 24,214 vehicles due to a software issue. The stock move erases Rivian’s year-to-date gain and turns the company negative on the year.

Rivian’s 2025 model year R1S and R1T are affected by the defect, which was identified after a vehicle’s hands-free highway assist software failed to identify another vehicle on the road, causing a low-speed collision. Rivian said it’s released an over-the-air update to fix the issue.

The recall marks Rivian’s fifth this year, affecting nearly 70,000 of its vehicles.

Rivian’s shares are down more than 20% from their 2025 high, which came prior to the passage of President Trump’sbig, beautiful bill.” Through the legislation, the $7,500 EV tax credit is set to expire at the end of the month.

markets

Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths

Vaccine makers are falling after The Washington Post reported that the Trump administration plans to link the coronavirus vaccine to 25 child deaths.

Moderna and Pfizer, the two companies who sell the vaccine in the US, fell by more than 5% and 2%, respectively. The coronavirus vaccine is virtually the only revenue driver for Moderna, while Pfizer has a larger and more diverse portfolio.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.